Japan· JP-1311706Q2022
アトロピン硫酸塩水和物
A atropine product containing アトロピン硫酸塩水和物, registered in Japan by ロートニッテン, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Atropine is registered in 16 of 19 countries.
Countries holding a registration under ATC A03BA01 (atropine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 9 of them publish a price we can compare per daily dose
Atropine · ATC A03BA01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アトロピン硫酸塩水和物
- Manufacturer
- ロートニッテン
- Country
- Japan (JP)
- ATC code
- A03BA01
- ATC class
- Atropine
- Defined daily dose
- 1.5 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
435 interactions on record for atropine.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atropine · interactions on record
435 records
- 6 severe
- 205 moderate
- 18 minor
- 206 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- TopiramatN02CX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A03BA01
Atropine, as other registers publish it.
- United KingdomActonorm oral powderWallace Manufacturing Chemists Ltd
- United StatesATROPEN Auto-InjectorMeridian Medical Technologies LLC
- United StatesATROPEN Auto-InjectorMeridian Medical Technologies LLC
- United StatesATROPEN Auto-InjectorMeridian Medical Technologies LLC
- United StatesATROPEN Auto-InjectorMeridian Medical Technologies LLC
- United StatesATROPEN Auto-InjectorMeridian Medical Technologies LLC
- FinlandAtropinOrifarm Oy
- FinlandAtropinOrifarm Oy
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e43a74ae-4b96-44e9-ab35-c21c505dbeb1 GET /v1/drugs/e43a74ae-4b96-44e9-ab35-c21c505dbeb1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１％５ｍＬ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1311706Q2022",
"category": "外用薬",
"price_yen": 296.6,
"generic_name": "アトロピン硫酸塩水和物",
"product_name_jp": null,
"therapeutic_class": "1311",
"transitional_expiry": null
}See everything about atropine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.